Strikingly, data from 169 cancer cell lines from the Cancer Cell Line Encyclopedia (CCLE) showed that only those lines harboring MYC amplification were significantly more sensitive to T‐025, making amplified MYC a strong biomarker candidate. The gene discussed is MYC; the disease is cancer.